Eyewash Solution Recalled for Manufacturing Compliance Deviations
Honeywell Inc. is recalling FENDALL 2000 PURE FLOW eyewash solution due to Current Good Manufacturing Practice deviations. The recall affects 10,605 cartridges distributed nationwide in the USA and Canada with expiration dates through June 2025.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary recall initiated by the manufacturer due to CGMP deviations. No specific harm, injuries, or illnesses are documented in the source, and the recall is precautionary in nature.
Plain-English summary
Honeywell Inc. has recalled FENDALL 2000 PURE FLOW (Purified Water), a saline eyewash solution sold in 7.9-gallon cartridges designed for Fendall 2000 eyewash stations. The recall involves 10,605 cartridges with manufacturer catalog number 32-002050-0000 and expiration dates through June 2025.
The recall was initiated by Honeywell on March 29, 2024, due to Current Good Manufacturing Practice (CGMP) deviations in the product's manufacture. This was a voluntary recall initiated by the firm, and the FDA classified it as a Class II recall. The recall was terminated on September 30, 2024.
The affected eyewash solution was distributed nationwide throughout the USA and Canada. Consumers and workplace safety personnel should check their inventory for cartridges matching the recalled product number and expiration date.
The recalled product
- Product
- FENDALL 2000 PURE FLOW (PURIFIED WATER)
- Brand
- FENDALL 2000 PURE FLOW
- Manufacturer
- HONEYWELL INC
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Manufacturer's Product Number/ Catalog Number: 32-002050-0000
- Exp 06/21/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27